Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1996-5-29
|
pubmed:abstractText |
Using recombinant proteins as standards, we calculated the amount of Vpr and Vpx present in HIV-2ROD particles. We find 2000-3000 copies of Vpx per particle but only 40-50 copies of Vpr. We investigated the reasons for this discrepancy between Vpx and Vpr and found that viral factors, including HIV-2 Vpx, do not restrict its incorporation. Instead, the accumulation of HIV-2ROD Vpr during infection is restricted by a short protein half-life which acts to limit its virion incorporation. The half-life of HIV-2 Vpr was calculated to be about 90 min, while HIV-2 Vpx and HIV-1 Vpr had half-lifes of 36 and 20 hr, respectively. Moreover, while both HIV-1 Vpr and HIV-2 Vpr cause cells to accumulate in G2 of the cell cycle, the effect of HIV-2 Vpr is attenuated relative to HIV-1 Vpr. Thus, protein stability correlates with both the function of Vpr and its virion incorporation.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Gene Products, vpr,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Fusion Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/VPX protein, Human...,
http://linkedlifedata.com/resource/pubmed/chemical/Viral Regulatory and Accessory...,
http://linkedlifedata.com/resource/pubmed/chemical/vpr Gene Products, Human...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0042-6822
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
218
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
326-34
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8610459-Cell Cycle,
pubmed-meshheading:8610459-Cell Line,
pubmed-meshheading:8610459-Gene Products, vpr,
pubmed-meshheading:8610459-HIV-1,
pubmed-meshheading:8610459-HIV-2,
pubmed-meshheading:8610459-Half-Life,
pubmed-meshheading:8610459-HeLa Cells,
pubmed-meshheading:8610459-Humans,
pubmed-meshheading:8610459-Recombinant Fusion Proteins,
pubmed-meshheading:8610459-T-Lymphocytes,
pubmed-meshheading:8610459-Viral Regulatory and Accessory Proteins,
pubmed-meshheading:8610459-Virion,
pubmed-meshheading:8610459-vpr Gene Products, Human Immunodeficiency Virus
|
pubmed:year |
1996
|
pubmed:articleTitle |
Protein stability influences human immunodeficiency virus type 2 Vpr virion incorporation and cell cycle effect.
|
pubmed:affiliation |
Fred Hutchinson Cancer Research Center, Division of Molecular Medicine, Seattle, Washington 98104, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|